210 related articles for article (PubMed ID: 31516038)
1. Circulating Cell Free Nuclear DNA, Mitochondrial DNA and Global DNA Methylation: Potential Noninvasive Biomarkers for Breast Cancer Diagnosis.
Pasha HA; Rezk NA; Riad MA
Cancer Invest; 2019; 37(9):432-439. PubMed ID: 31516038
[TBL] [Abstract][Full Text] [Related]
2. Plasma Circulating Cell-free Nuclear and Mitochondrial DNA as Potential Biomarkers in the Peripheral Blood of Breast Cancer Patients.
Mahmoud EH; Fawzy A; Ahmad OK; Ali AM
Asian Pac J Cancer Prev; 2015; 16(18):8299-305. PubMed ID: 26745076
[TBL] [Abstract][Full Text] [Related]
3. Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.
Kohler C; Radpour R; Barekati Z; Asadollahi R; Bitzer J; Wight E; Bürki N; Diesch C; Holzgreve W; Zhong XY
Mol Cancer; 2009 Nov; 8():105. PubMed ID: 19922604
[TBL] [Abstract][Full Text] [Related]
4. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic potential of circulating cell-free nuclear and mitochondrial DNA for several cancer types and nonmalignant diseases: A study on suspected cancer patients.
Sundquist K; Sundquist J; Hedelius A; Memon AA
Mol Carcinog; 2020 Dec; 59(12):1362-1370. PubMed ID: 33051887
[TBL] [Abstract][Full Text] [Related]
6. Methylation patterns in serum DNA for early identification of disseminated breast cancer.
Widschwendter M; Evans I; Jones A; Ghazali S; Reisel D; Ryan A; Gentry-Maharaj A; Zikan M; Cibula D; Eichner J; Alunni-Fabbroni M; Koch J; Janni WJ; Paprotka T; Wittenberger T; Menon U; Wahl B; Rack B; Lempiäinen H
Genome Med; 2017 Dec; 9(1):115. PubMed ID: 29268762
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide cell-free DNA methylation analyses improve accuracy of non-invasive diagnostic imaging for early-stage breast cancer.
Liu J; Zhao H; Huang Y; Xu S; Zhou Y; Zhang W; Li J; Ming Y; Wang X; Zhao S; Li K; Dong X; Ma Y; Qian T; Chen X; Xing Z; Zhang Y; Chen H; Liu Z; Pang D; Zhou M; Wu Z; Wang X; Wang X; Wu N; Su J
Mol Cancer; 2021 Feb; 20(1):36. PubMed ID: 33608029
[TBL] [Abstract][Full Text] [Related]
8. Plasma ALU-247, ALU-115, and cfDNA Integrity as Diagnostic and Prognostic Biomarkers for Breast Cancer.
Hussein NA; Mohamed SN; Ahmed MA
Appl Biochem Biotechnol; 2019 Mar; 187(3):1028-1045. PubMed ID: 30151636
[TBL] [Abstract][Full Text] [Related]
9. Examination of methylation changes of
Shirkavand A; Boroujeni ZN; Aleyasin SA
Indian J Cancer; 2018; 55(4):366-371. PubMed ID: 30829272
[TBL] [Abstract][Full Text] [Related]
10. An automated, high-throughput methodology optimized for quantitative cell-free mitochondrial and nuclear DNA isolation from plasma.
Ware SA; Desai N; Lopez M; Leach D; Zhang Y; Giordano L; Nouraie M; Picard M; Kaufman BA
J Biol Chem; 2020 Nov; 295(46):15677-15691. PubMed ID: 32900851
[TBL] [Abstract][Full Text] [Related]
11. Blood-based DNA methylation as biomarker for breast cancer: a systematic review.
Tang Q; Cheng J; Cao X; Surowy H; Burwinkel B
Clin Epigenetics; 2016; 8():115. PubMed ID: 27895805
[TBL] [Abstract][Full Text] [Related]
12. Cell-free mitochondrial DNA increases in maternal circulation during healthy pregnancy: a prospective, longitudinal study.
Cushen SC; Sprouse ML; Blessing A; Sun J; Jarvis SS; Okada Y; Fu Q; Romero SA; Phillips NR; Goulopoulou S
Am J Physiol Regul Integr Comp Physiol; 2020 Feb; 318(2):R445-R452. PubMed ID: 31913687
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma.
Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA
Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.
Yang R; Pfütze K; Zucknick M; Sutter C; Wappenschmidt B; Marme F; Qu B; Cuk K; Engel C; Schott S; Schneeweiss A; Brenner H; Claus R; Plass C; Bugert P; Hoth M; Sohn C; Schmutzler R; Bartram CR; Burwinkel B
Int J Cancer; 2015 Apr; 136(8):1845-55. PubMed ID: 25213452
[TBL] [Abstract][Full Text] [Related]
15. Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers.
Arko-Boham B; Aryee NA; Blay RM; Owusu EDA; Tagoe EA; Doris Shackie ES; Debrah AB; Adu-Aryee NA
Cancer Genet; 2019 Jun; 235-236():65-71. PubMed ID: 31105051
[TBL] [Abstract][Full Text] [Related]
16.
Zang Z; Yin Y; Liu C; Zhu Q; Huang X; Li H; Yang R
Epigenetics; 2024 Dec; 19(1):2352683. PubMed ID: 38723244
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation and breast cancer: A way forward (Review).
Vietri MT; D'Elia G; Benincasa G; Ferraro G; Caliendo G; Nicoletti GF; Napoli C
Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34726251
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNA.
Yang Z; Qi W; Sun L; Zhou H; Zhou B; Hu Y
Adv Clin Exp Med; 2019 Mar; 28(3):355-360. PubMed ID: 30516882
[TBL] [Abstract][Full Text] [Related]
19. Maternal trans-general analysis of the human mitochondrial DNA pattern.
Han X; Zhao Z; Zhang M; Li G; Yang C; Du F; Wang J; Zhang Y; Wang Y; Jia Y; Li B; Sun Y
Biochem Biophys Res Commun; 2017 Nov; 493(1):643-649. PubMed ID: 28865962
[TBL] [Abstract][Full Text] [Related]
20. The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer.
Widschwendter M; Zikan M; Wahl B; Lempiäinen H; Paprotka T; Evans I; Jones A; Ghazali S; Reisel D; Eichner J; Rujan T; Yang Z; Teschendorff AE; Ryan A; Cibula D; Menon U; Wittenberger T
Genome Med; 2017 Dec; 9(1):116. PubMed ID: 29268796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
